Abstract
Connexins and pannexins comprise two families of transmembrane proteins ubiquitously distributed in vertebrates. Most cell types express more than 1 connexin or pannexin. Members of the same protein family form homo- or hetero-hexamers termed hemichannels. Hemichannels are pathways for the transmembrane diffusional exchange of ions and small molecules. Several human genetic diseases are associated with connexin mutants that may form hemichannels with increased or reduced activity. Pro-inflammatory conditions of different duration and/or intensity can lead to acute or chronic increase in hemichannel activity. Non-lethal stimuli can lead to transient increases in hemichannel activity (required for normal autocrine and/or paracrine cell signaling that might lead to preconditioning responses), whereas lethal stimuli induce long lasting hemichannel-mediated membrane permeabilization that accelerate cell death. Thus, in addition to transporters that mediate active and facilitated transport, the plasma membrane of most cells contains diffusional transporters (hemichannels) that are essential for normal cell functioning; their malfunctioning can cause or worsen a pathological condition.
Keywords: Hemichannel, human
Current Vascular Pharmacology
Title: Dysfunctions of the Diffusional Membrane Pathways Mediated Hemichannels in Inherited and Acquired Human Diseases
Volume: 7 Issue: 4
Author(s): Kurt A. Schalper, Juan A. Orellana, Viviana M. Berthoud and Juan C. Saez
Affiliation:
Keywords: Hemichannel, human
Abstract: Connexins and pannexins comprise two families of transmembrane proteins ubiquitously distributed in vertebrates. Most cell types express more than 1 connexin or pannexin. Members of the same protein family form homo- or hetero-hexamers termed hemichannels. Hemichannels are pathways for the transmembrane diffusional exchange of ions and small molecules. Several human genetic diseases are associated with connexin mutants that may form hemichannels with increased or reduced activity. Pro-inflammatory conditions of different duration and/or intensity can lead to acute or chronic increase in hemichannel activity. Non-lethal stimuli can lead to transient increases in hemichannel activity (required for normal autocrine and/or paracrine cell signaling that might lead to preconditioning responses), whereas lethal stimuli induce long lasting hemichannel-mediated membrane permeabilization that accelerate cell death. Thus, in addition to transporters that mediate active and facilitated transport, the plasma membrane of most cells contains diffusional transporters (hemichannels) that are essential for normal cell functioning; their malfunctioning can cause or worsen a pathological condition.
Export Options
About this article
Cite this article as:
Schalper A. Kurt, Orellana A. Juan, Berthoud M. Viviana and Saez C. Juan, Dysfunctions of the Diffusional Membrane Pathways Mediated Hemichannels in Inherited and Acquired Human Diseases, Current Vascular Pharmacology 2009; 7 (4) . https://dx.doi.org/10.2174/157016109789043937
DOI https://dx.doi.org/10.2174/157016109789043937 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature
Current Drug Safety Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Current Medicinal Chemistry Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Current Pharmaceutical Design Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients
Current Pharmaceutical Design Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Current Pharmaceutical Design Boron Nitride Nanotubes: Production, Properties, Biological Interactions and Potential Applications as Therapeutic Agents in Brain Diseases
Current Nanoscience Triazole and Oxadiazole Containing Natural Products: A Review
The Natural Products Journal Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments
Current Drug Targets Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Cellomics as Integrative Omics for Cancer
Current Proteomics Hybrid PET Imaging in Neurologic Disease: PET/MRI Rather than PET/CT
Current Medical Imaging Design of Telomerase Inhibitors for the Treatment of Cancer
Current Pharmaceutical Design Multi-Modality Discrimination of Brain Glioma Grades Using Diffusion Tensor and Spectroscopic MRI
Recent Patents on Medical Imaging Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Current Pharmacogenomics Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Novel Benzimidazole Derivatives: Cytotoxic and Apoptotic Properties on Lung Cancer Cell Line
Letters in Drug Design & Discovery Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism
Current Pharmaceutical Biotechnology A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets